Cargando…

Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome

Faecal microbiota transfer (FMT) consists of the introduction of new microbial communities into the intestine of a patient, with the aim of restoring a disturbed gut microbiota. Even though it is used as a potential treatment for various diseases, it is unknown how the host mucosa responds to FMT. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holster, Savanne, Hooiveld, Guido J., Repsilber, Dirk, de Vos, Willem M., Brummer, Robert J., König, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843426/ https://www.ncbi.nlm.nih.gov/pubmed/31597320 http://dx.doi.org/10.3390/biom9100586

Ejemplares similares

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study
por: Holster, Savanne, et al.
Publicado: (2019)

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2023)

Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting
por: König, Julia, et al.
Publicado: (2017)

Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating
por: Holvoet, Tom, et al.
Publicado: (2017)

Increased colon transit time and faecal load in irritable bowel syndrome
por: Raahave, Dennis, et al.
Publicado: (2021)

Cytokine Response after Stimulation with Key Commensal Bacteria Differ in Post-Infectious Irritable Bowel Syndrome (PI-IBS) Patients Compared to Healthy Controls
por: Sundin, Johanna, et al.
Publicado: (2015)

Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Face-to-Face Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: The Effects on Gastrointestinal and Psychiatric Symptoms
por: Edebol-Carlman, Hanna, et al.
Publicado: (2017)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
por: Ahluwalia, Bani, et al.
Publicado: (2021)

Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients
por: Nagel, Robyn, et al.
Publicado: (2016)

Faecal microbiota transplantation simultaneously ameliorated patient's essential tremor and irritable bowel syndrome
por: Liu, Xu‐juan, et al.
Publicado: (2020)

Consensus report: faecal microbiota transfer – clinical applications and procedures
por: König, J., et al.
Publicado: (2016)

The microbiome of the oral mucosa in irritable bowel syndrome
por: Fourie, Nicolaas H., et al.
Publicado: (2016)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
por: Sundin, Johanna, et al.
Publicado: (2020)

Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome
por: Emmanuel, Anton, et al.
Publicado: (2016)

Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea
por: Liu, Jing, et al.
Publicado: (2022)

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)
por: El-Salhy, Magdy, et al.
Publicado: (2019)

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
por: El-Salhy, Magdy, et al.
Publicado: (2020)

Effects of faecal microbiota transplantation on the small intestinal mucosa in systemic sclerosis
por: Strahm, Noemi, et al.
Publicado: (2023)

Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients
por: Čipčić Paljetak, Hana, et al.
Publicado: (2022)

The Impact of Low-Level Iron Supplements on the Faecal Microbiota of Irritable Bowel Syndrome and Healthy Donors Using In Vitro Batch Cultures
por: Poveda, Carlos, et al.
Publicado: (2020)

Faecal incontinence—the hidden scourge of irritable bowel syndrome: a cross-sectional study
por: Atarodi, Sima, et al.
Publicado: (2015)

Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?
por: Farup, Per G., et al.
Publicado: (2016)

Mucosa-Colonizing Microbiota Correlate With Host Autophagy Signaling in Patients With Inflammatory Bowel Disease
por: Wang, Wenxue, et al.
Publicado: (2022)

Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea: origin and effect of gut transit
por: Tooth, David, et al.
Publicado: (2014)

Irritable Bowel Syndrome, Gut Microbiota and Probiotics
por: Lee, Beom Jae, et al.
Publicado: (2011)

Gut Microbiota Manipulation in Irritable Bowel Syndrome
por: Mazzawi, Tarek
Publicado: (2022)

Adeno-associated virus vector intraperitoneal injection induces colonic mucosa and submucosa transduction and alters the diversity and composition of the faecal microbiota in rats
por: Ma, Li-Tian, et al.
Publicado: (2022)

The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
por: Haifer, Craig, et al.
Publicado: (2020)

Prokaryotic and Eukaryotic Fecal Microbiota in Irritable Bowel Syndrome Patients and Healthy Individuals Colonized With Blastocystis
por: Nourrisson, Céline, et al.
Publicado: (2021)

Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms
por: Cui, Xiufang, et al.
Publicado: (2021)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Phylogenetic microbiota profiling in fecal samples depends on combination of sequencing depth and choice of NGS analysis method
por: Rajan, Sukithar K., et al.
Publicado: (2019)

Protocol for faecal microbiota transplantation in irritable bowel syndrome: the MISCEAT study – a randomised, double-blind cross-over study using mixed microbiota from healthy donors
por: Hurych, Jakub, et al.
Publicado: (2022)

Toll-Like Receptor mRNA Expression Is Selectively Increased in the Colonic Mucosa of Two Animal Models Relevant to Irritable Bowel Syndrome
por: McKernan, Declan P., et al.
Publicado: (2009)

The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?
por: Ghoshal, Uday C., et al.
Publicado: (2012)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
por: Bennet, Sean M.P., et al.
Publicado: (2015)

Gut Microbiota-Based Therapies for Irritable Bowel Syndrome
por: Stern, Emily K, et al.
Publicado: (2018)

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
por: Xiao, Lin, et al.
Publicado: (2021)

Bile Acid and Gut Microbiota in Irritable Bowel Syndrome
por: Min, Yang Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7g3mvggpo02m56q53to4g1b46